{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:09:34Z","timestamp":1764785374371,"version":"3.41.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijtb.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T05:43:57Z","timestamp":1715924637000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study of the results of tuberculosis interferon-gamma release assays before and after the SARS CoV-2 pandemic"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1347-8332","authenticated-orcid":false,"given":"Ameni","family":"Jerbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lassaad","family":"Chtourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Hachicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hela","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouzia","family":"Ben Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Ben Moallem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofien","family":"Baklouti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Tahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijtb.2024.05.007_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11020408","article-title":"Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms","volume":"11","author":"Brown","year":"2023","journal-title":"Vaccines"},{"issue":"October","key":"10.1016\/j.ijtb.2024.05.007_bib2","first-page":"1","article-title":"Adaptive immunity to SARS-CoV-2 infection: a systematic review","volume":"13","author":"Silva","year":"2022","journal-title":"Front Immunol"},{"issue":"1339","key":"10.1016\/j.ijtb.2024.05.007_bib3","first-page":"1","article-title":"SARS-CoV-2 : a master of immune evasion","volume":"10","author":"Rubio-casillas","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijtb.2024.05.007_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112420","article-title":"Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets","volume":"145","author":"Farahani","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijtb.2024.05.007_bib5","series-title":"Host Microbe","article-title":"SLL. Evasion of neutralizing antibody response by the SARS-CoV-2 BA.2.75 variant","author":"Qu","year":"2022"},{"issue":"5","key":"10.1016\/j.ijtb.2024.05.007_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jmcb\/mjac034","article-title":"The putative mechanism of lymphopenia in COVID-19 patients","volume":"14","author":"Wang","year":"2022","journal-title":"J Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.ijtb.2024.05.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v15071417","article-title":"COVID-19: S-peptide RBD 484\u2013508 induces IFN-\u03b3 T-cell response in na\u00efve-to-infection and unvaccinated subjects with close contact with SARS-CoV-2-positive patients","volume":"15","author":"Murdocca","year":"2023","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijtb.2024.05.007_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.immuni.2009.03.013","article-title":"Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-\u03b3 and interleukin-12","volume":"30","author":"Schulz","year":"2009","journal-title":"Immunity"},{"issue":"September","key":"10.1016\/j.ijtb.2024.05.007_bib9","first-page":"1","article-title":"Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis","volume":"14","author":"Booysen","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2024.05.007_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ccm.2019.07.007","article-title":"Diagnostic tests for latent tuberculosis infection","volume":"40","author":"Haas","year":"2019","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.ijtb.2024.05.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/life12020244","article-title":"In patients with severe COVID\u201019, the profound decrease in the peripheral blood T\u2010cell subsets is correlated with an increase of QuantiFERON\u2010TB gold plus indeterminate rates and reflecting a reduced interferon\u2010gamma production","volume":"12","author":"Imeneo","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ijtb.2024.05.007_bib12","first-page":"19","article-title":"Clinical and epidemiological correlates of low IFN-gamma responses in mitogen tube of QuantiFERON assay in tuberculosis infection screening during the COVID-19 pandemic: a population-based marker of COVID-19 mortality?","author":"Palacios-Guti\u00e9rrez","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.ijtb.2024.05.007_bib13","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.ijid.2021.02.090","article-title":"Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2","volume":"113","author":"Petrone","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"S2","key":"10.1016\/j.ijtb.2024.05.007_bib14","first-page":"45","article-title":"Influence of cytokine release syndrome in severe COVID-19 patients treated with tocilizumab over the quantiferon TB gold plus results","volume":"57","author":"S\u00e1nchez-Mart\u00ednez","year":"2021","journal-title":"Cartas cient\u00edficas\/Arch Bronconeumol"},{"issue":"5","key":"10.1016\/j.ijtb.2024.05.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10050918","article-title":"Clinical significance of indeterminate quantiferon-tb gold plus assay results in hospitalized covid-19 patients with severe hyperinflammatory syndrome","volume":"10","author":"Solanich","year":"2021","journal-title":"J Clin Med"},{"issue":"January","key":"10.1016\/j.ijtb.2024.05.007_bib16","article-title":"Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy","volume":"175","author":"Torre","year":"2020","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.ijtb.2024.05.007_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.5588\/ijtld.22.0283","article-title":"IGRA test for TB in COVID-19: role of corticosteroids","volume":"26","author":"Granozzi","year":"2022","journal-title":"Int J Tubercul Lung Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2024.05.007_bib18","first-page":"409","article-title":"The pitfalls of mining for QuantiFERON gold in severely ill patients with COVID-19","volume":"6","author":"Cortes","year":"2022","journal-title":"Mayo Clin Proc: Innovations, Quality & Outcomes"},{"issue":"10","key":"10.1016\/j.ijtb.2024.05.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.00811-21","article-title":"Indeterminate QuantiFERON gold plus results reveal deficient interferon gamma responses in severely III COVID-19 Patients","volume":"59","author":"Ward","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijtb.2024.05.007_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1695","article-title":"Prevalence of indeterminate tuberculosis interferon\u2010gamma release assays in COVID\u201019 patients: systematic review and meta\u2010analysis","volume":"6","author":"Ben Tekaya","year":"2023","journal-title":"Health Sci. Reports"},{"issue":"1","key":"10.1016\/j.ijtb.2024.05.007_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI140491","article-title":"Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection","volume":"131","author":"Files","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijtb.2024.05.007_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886431","article-title":"Remodeling of T Cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection","volume":"13","author":"Wiech","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ijtb.2024.05.007_bib24","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing : a systematic review","volume":"4","author":"Zyl-smit","year":"2009","journal-title":"PLoS One"},{"unstructured":"Qiagen. QuantiFERON \u00ae - TB Gold Plus (QFT \u00ae -Plus) ELISA Package Insert 2\/2015. Qiagen,Hilden,Germany..","key":"10.1016\/j.ijtb.2024.05.007_bib25"},{"key":"10.1016\/j.ijtb.2024.05.007_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12879-021-06141-4","article-title":"Interferon-gamma release assay levels and risk of progression to active tuberculosis : a systematic review and dose-response meta- regression analysis","volume":"21","author":"Ledesma","year":"2021","journal-title":"BMC Infect Dis"},{"unstructured":"CDC. Guidelines for Using the QuantiFERON\u00ae-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States. Accessed September 11, 2023. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5415a4.htm.","key":"10.1016\/j.ijtb.2024.05.007_bib27"},{"issue":"May","key":"10.1016\/j.ijtb.2024.05.007_bib28","first-page":"1","article-title":"Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijtb.2024.05.007_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.arcmed.2011.02.001","article-title":"Indeterminate results of QuantiFERON-TB gold in-tube assay in nonimmunosuppressed children","volume":"42","author":"Topi","year":"2011","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ijtb.2024.05.007_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154803","article-title":"Interferon gamma release assay versus tuberculin skin testing among healthcare workers of highly diverse origin in a moderate tuberculosis burden country","volume":"11","author":"Hajoj","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2024.05.007_bib31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.00075008","article-title":"Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice","volume":"33","author":"Kobashi","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijtb.2024.05.007_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijtb.2024.05.007_bib33","article-title":"QuantiFERON test interpretation in patients receiving immunosuppressive agents : an alert","volume":"49","author":"Blancher","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ijtb.2024.05.007_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ibd\/izx019","article-title":"Indeterminate QuantiFERON-TB gold increases likelihood of inflammatory bowel disease treatment delay and hospitalization","volume":"24","author":"Vajravelu","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2024.05.007_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1128\/JCM.01547-13","article-title":"Significant reduction in rate of indeterminate results of the QuantiFERON-TB gold in-tube test by shortening incubation delay","volume":"52","author":"Yun","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.ijtb.2024.05.007_bib36","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/CVI.00290-13","article-title":"Effect of prolonged incubation time on results of the QuantiFERON TB gold in-tube assay for diagnosis of latent tuberculosis infection","volume":"20","author":"won","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"January","key":"10.1016\/j.ijtb.2024.05.007_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijid.2022.06.044","article-title":"Changes in interferon- \u03b3 release assay readout after COVID-19 vaccination: a prospective cohort study","volume":"122","author":"Chen","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.ijtb.2024.05.007_bib38","first-page":"1816","article-title":"Muhammad Arsalan Qureshi AC. Lymphopenia : a useful predictor of COVID-19 disease severity and mortality","volume":"10","author":"Toori","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijtb.2024.05.007_bib39","first-page":"1","article-title":"Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis","volume":"4","author":"Huang","year":"2020","journal-title":"J intensive care"},{"key":"10.1016\/j.ijtb.2024.05.007_bib40","first-page":"1","article-title":"Persistent symptoms and lab abnormalities in patients who recovered from COVID - 19","author":"Varghese","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijtb.2024.05.007_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2217\/fvl-2022-0218","article-title":"Effects of COVID-19 and vaccination on the human immune system : cases of lymphopenia and autoimmunity","volume":"18","author":"Gerlach","year":"2023","journal-title":"Future Virol"},{"issue":"FebruarY","key":"10.1016\/j.ijtb.2024.05.007_bib42","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570724000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570724000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:45:56Z","timestamp":1753224356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570724000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0019570724000829"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.007","relation":{},"ISSN":["0019-5707"],"issn-type":[{"type":"print","value":"0019-5707"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of the results of tuberculosis interferon-gamma release assays before and after the SARS CoV-2 pandemic","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}